Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556395 · ClinicalTrials.gov registry record

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

A clinical trial of Ischemic Stroke, sponsored by Johns Hopkins University.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT05556395 is a study of Ischemic Stroke that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 150 participants, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556395, a study of Ischemic Stroke, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to gain a better understanding of why some individuals who have suffered a stroke experience post-stroke cognitive decline. Specifically this study is testing whether global disruption of the blood-brain barrier detected at the time of the stroke is informative about the risk of post-stroke cognitive decline over the next 3 years.

Conditions Studied

Ischemic Stroke

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-04-01
Est. Completion 2027-04-01

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05556395

The ClinicalTrials.gov registry entry for NCT05556395 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT05556395 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05556395 about?

NCT05556395 is a clinical study titled "Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline". The goal of this study is to gain a better understanding of why some individuals who have suffered a stroke experience post-stroke cognitive decline. Specifically this study is testing whether global disruption of the blood-brain barrier detected at the time of the stroke is informative about the ri...

What is the current status of trial NCT05556395?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-04-01. Estimated completion is 2027-04-01.

What conditions does trial NCT05556395 study?

This clinical trial studies the following conditions: Ischemic Stroke.

Who is sponsoring clinical trial NCT05556395?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05556395 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Stroke

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.